Accelerating Cell and Gene Therapy Development with Proven CDMO Expertise
Expert insights, real‑world strategies, and scalable solutions for advanced therapy innovators
Advancing cell and gene therapies demands deep technical expertise, regulatory insight, and scalable manufacturing solutions. This curated resource hub brings together scientific thought leadership, practical case studies, and expert-led discussions to support every stage of development, from early process design to commercial readiness.
Explore proven approaches to viral vector and plasmid DNA manufacturing, regulatory and CMC best practices, and innovative cell therapy platforms designed to reduce risk and accelerate timelines.
Scaling Up for Success: Regulatory and Process Strategies for CGT Drug Products Webinar
Understand how to align regulatory considerations with process optimization throughout the entire drug product lifecycle with this webinar on demand. Gain insights on regulatory, testing, and process milestones that pave a successful path to GMP manufacturing and commercialization, including IND and BLA applications.
AAV Production for Rare Disease Therapies: From Challenge to Solution Webinar
Join experts from Charles River and FOXG1 Research Foundation for an in-depth discussion on overcoming AAV manufacturing challenges for rare disease programs. Learn actionable solutions to improve productivity, quality, and speed while navigating complex development and regulatory requirements.
Cell Therapy Commercialization: GMP Manufacturing to Launch Playbook
From GMP manufacturing and scale-up to launch readiness, download our series of practical, executive-level insights on cell therapy commercialization. Discover how to reduce risk, accelerate timelines, and confidently partner with an experienced CDMO from clinic to commercial success.
DownloadCell and Gene-modified Cell Therapy CMC Whitepaper
Bringing together expert insights on platform development, comparability, potency assays, raw material qualification, and regulatory readiness, this whitepaper highlights where analytics play a decisive role in de-risking development. Learn how proactive CMC planning and analytical strategies can help avoid clinical delays, manufacturing failures, and approval hurdles as your program advances.
DownloadCell Therapy Flex Platform Case Study
When speed matters, smart execution wins. Discover how an autologous CAR‑T program advanced from first process run to IND approval in just eight months—by streamlining cell and gene therapy process development, testing, tech transfer, and GMP readiness.
DownloadViral Vector Manufacturing Whitepaper
This whitepaper explores key considerations across viral vector manufacturing, from process development and scale‑up to managing the “QC tax” and differing regulatory standards. Drawing on extensive viral vector CDMO experience, explore practical approaches to building robust, fit‑for‑purpose manufacturing strategies that support clinical progression and position developers for long‑term success.
DownloadPlasmid DNA Manufacturing Whitepaper
Explore critical considerations for plasmid DNA development, from process design through GMP manufacturing. Learn how robust strategies can improve quality, scalability, and supply reliability for viral vector and cell and gene therapy programs.
DownloadOptimizing iPSCs Expansion for Cell Therapy Manufacturing Poster
Discover data-driven approaches to improving iPSC expansion and consistency. This poster highlights process optimization strategies that enhance scalability and robustness, supporting efficient manufacturing of next-generation cell therapies.
Download